HealthEquity’s (HQY) “Outperform” Rating Reiterated at Barrington Research

Barrington Research reissued their outperform rating on shares of HealthEquity (NASDAQ:HQY) in a report issued on Friday, Benzinga reports. Barrington Research currently has a $105.00 target price on the stock.

A number of other brokerages have also issued reports on HQY. Deutsche Bank Aktiengesellschaft increased their price target on HealthEquity from $102.00 to $103.00 and gave the company a buy rating in a research note on Wednesday, September 4th. JMP Securities reiterated a market outperform rating and set a $105.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Royal Bank of Canada reiterated an outperform rating and set a $92.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Raymond James increased their price objective on HealthEquity from $100.00 to $105.00 and gave the company an outperform rating in a research report on Friday, June 7th. Finally, Bank of America cut their price objective on HealthEquity from $105.00 to $100.00 and set a buy rating for the company in a research report on Wednesday, September 4th. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of Moderate Buy and a consensus price target of $103.83.

HealthEquity Stock Performance

Shares of NASDAQ HQY opened at $79.53 on Friday. The stock has a fifty day moving average price of $76.17 and a two-hundred day moving average price of $79.31. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. The firm has a market cap of $6.92 billion, a P/E ratio of 86.45, a PEG ratio of 1.19 and a beta of 0.52. HealthEquity has a 1 year low of $61.81 and a 1 year high of $88.26.

Insider Activity

In other news, Vice Chairman Stephen Neeleman sold 35,000 shares of the stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total value of $2,795,100.00. Following the completion of the sale, the insider now owns 89,769 shares in the company, valued at $7,168,952.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other HealthEquity news, Director Frank Corvino sold 7,705 shares of the business’s stock in a transaction dated Monday, July 8th. The stock was sold at an average price of $81.89, for a total value of $630,962.45. Following the transaction, the director now owns 6,070 shares in the company, valued at $497,072.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of the business’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $79.86, for a total value of $2,795,100.00. Following the completion of the transaction, the insider now owns 89,769 shares in the company, valued at approximately $7,168,952.34. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of HQY. Motley Fool Asset Management LLC lifted its position in shares of HealthEquity by 3,001.0% in the first quarter. Motley Fool Asset Management LLC now owns 3,762,064 shares of the company’s stock worth $307,097,000 after buying an additional 3,640,748 shares during the last quarter. Norges Bank acquired a new stake in shares of HealthEquity in the fourth quarter worth about $43,482,000. Vaughan Nelson Investment Management L.P. acquired a new stake in shares of HealthEquity in the first quarter worth about $49,443,000. Wasatch Advisors LP lifted its position in shares of HealthEquity by 8.3% in the first quarter. Wasatch Advisors LP now owns 7,409,080 shares of the company’s stock worth $604,803,000 after buying an additional 569,249 shares during the last quarter. Finally, Mackenzie Financial Corp lifted its position in shares of HealthEquity by 16.0% in the second quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock worth $203,822,000 after buying an additional 325,906 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.